RPL32 Promotes Lung Cancer Progression by Facilitating p53 Degradation
Lung cancer is the leading cause of cancer death worldwide, and the overall survival rate of advanced lung cancer patients is unsatisfactory. Ribosomal proteins (RPs) play important roles in carcinogenesis. However, the role of RPL32 in lung cancer has not been demonstrated. Here, we report that RPL...
Saved in:
Main Authors: | Jiansheng Xie (Author), Wei Zhang (Author), Xiaojing Liang (Author), Chong Shuai (Author), Yubin Zhou (Author), Hongming Pan (Author), Yunhai Yang (Author), Weidong Han (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RPL32 Promotes Lung Cancer Progression by Facilitating p53 Degradation
by: Jiansheng Xie, et al.
Published: (2020) -
Development of Store-Operated Calcium Entry-Targeted Compounds in Cancer
by: Xiaojing Liang, et al.
Published: (2021) -
Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway
by: Bingwu Wang, et al.
Published: (2022) -
miR-26a attenuates colitis and colitis-associated cancer by targeting the multiple intestinal inflammatory pathways
by: Wei Zhang, et al.
Published: (2021) -
RHBDF1 deficiency suppresses melanoma glycolysis and enhances efficacy of immunotherapy by facilitating glucose-6-phosphate isomerase degradation via TRIM32
by: Lei Wang, et al.
Published: (2023)